Search clinical trials for: cytogenetic analysis on tumour tissue

Total 390 results

Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma (MicroGenUM)

Uveal Melanoma

Italy
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Multiple Myeloma | Acute Lymphoblastic Leukemia | Acute Leukemia | Myelodysplastic Syndrome

United States
Centre Oscar Lambret

Completed

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (MetLung)

Non Small Cell Lung Cancer

France
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

Leukemia

Australia
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia

Leukemia
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Unknown

BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer (BASE HSP110)

Cancer of Colon | Rectum Cancer

France
Children's Oncology Group
National Cancer Institute (NCI)

Completed

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Leukemia
GWT-TUD GmbH

Terminated

Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY (SAMBA)

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

France, Germany
King Faisal Specialist Hospital & Research Center

Completed

Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Lymphoma, Non-Hodgkin | Hodgkin Disease

Saudi Arabia
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

Lymphoma | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant Condition
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

Leukemia

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

Multiple Myeloma | Plasma Cell Myeloma | Precancerous Condition

United States
Cancer Trials Ireland

Completed

Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Leukemia

United States, Ireland, Israel, Germany
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

Lymphoma
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Kidney Cancer
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Lymphoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia

Leukemia
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Head and Neck Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

Brain Tumors | Central Nervous System Tumors

United States, Australia, Canada
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Comparison of KRAS/BRAF Mutational Status With Conventional Techniques and Plasma Samples Analysis (KPLEX2)

Colorectal Cancer
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997

Leukemia
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Genetic Study of Familial Factors in Patients With Colon Cancer

Colorectal Cancer

United States
Centre Francois Baclesse
Fondation avenir; laboratoire Genzyme

Completed

Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study (SWEETMAC)

Thyroid Node | Indeterminate Cytology | Surgery Indication

France
Oxford University Hospitals NHS Trust

Unknown

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Myelodysplastic Syndromes | Leukemia

United Kingdom
Holy Cross Hospital, Maryland

Withdrawn

Personalizing Immune Checkpoint Inhibitor Therapy

Lung Cancer Stage IV

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Unknown

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Breast Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Sarcoma | Kidney Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Pleuropulmonary Blastoma | Hereditary Wilms Tumor
Hospital Clínico Universitario de Valladolid

Completed

Genomic Instability in Vascular Surgeons (IRADIENT)

Radiation Exposure | Cytogenetic Abnormality

Spain
CCTU- Cancer Theme
Cambridge University Hospitals NHS Foundation Trust; University of Cambridge

Unknown

LUCID - LUng Cancer CIrculating Tumour Dna Study (LUCID)

Non Small Cell Lung Cancer

United Kingdom
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

Leukemia
Istituto Clinico Humanitas

Unknown

Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy (MITOMARKER-MIM)

Bladder Cancer

Italy
Royal Marsden NHS Foundation Trust

Unknown

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer

Breast Cancer

United Kingdom
University Health Network, Toronto

Recruiting

Study of Biomarkers in Gynecological Cancers

Gynecologic Cancer

Canada
Royal Marsden NHS Foundation Trust

Unknown

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

Breast Cancer

United Kingdom
University Health Network, Toronto

Withdrawn

Molecular Profiling of Advanced Biliary Tract Cancers

Biliary Tract Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

Lymphoma | Nonneoplastic Condition
Centre Hospitalier Universitaire, Amiens

Withdrawn

Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients (SLAMF3)

Hepatocellular Carcinoma | Hepatocyte Receptor

France
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

Myelodysplastic Syndromes | Leukemia

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
National Cancer Institute (NCI)

Unknown

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

Breast Cancer
M.D. Anderson Cancer Center
Foundation Medicine

Completed

Genomic Profiling Assay in Phase I

Advanced Cancers

United States
Jules Bordet Institute

Completed

Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

Invasive Breast Cancer

Belgium
The Oxford Dental College, Hospital and Research...
Credora Life Sciences, India

Completed

Epithelial Mesenchymal Transition Markers in OSMF

Oral Submucous Fibrosis
Janssen Research & Development, LLC

Completed

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

Metastatic Prostate Cancer

United States, Korea, Republic of, Australia, Poland, Taiwan, France, Thailand, Malaysia, Russian Federation, Canada, Bulgaria, Italy, Spain, Turkey, Sweden, Israel, Belarus, Ukraine, Brazil, Argentina, Belgium, Denmark, United Kingdom and more
Istituto Ortopedico Rizzoli

Recruiting

Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project (GRACefUl)

Undifferentiated Round Cell Sarcoma

Italy
Dermatologic Cooperative Oncology Group

Recruiting

Multicenter Tissue Registry in Melanoma (TRIM)

Metastatic Melanoma

Germany
University of Freiburg

Completed

Intestinal Biomarker Analysis After ECP for ICI Colitis (IBA_ECP)

Colitis | Immune Checkpoint Inhibitor-Related Colitis

Germany
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

Melanoma (Skin)

United States
Assiut University

Unknown

PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia

Acute Myeloid Leukemia
Stanford University

Completed

Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

Lymphoma | Hodgkin Disease

United States

Search clinical trials for: cytogenetic analysis on tumour tissue

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations